D. Pentz, Ph.D., Named to American Society of Clinical Oncology Ethics
Rebecca D. Pentz,
Ph.D., Professor of Hematology and Oncology Research Ethics at The Winship
Cancer Institute at Emory University, recently was appointed to the
American Society of Clinical Oncology (ASCO) Ethics Committee. Dr. Pentz
received a recommendation for committee membership from Charles Bach,
M.D., executive vice president and chief executive officer of ASCO.
Dr. Pentz will serve on the
Ethics Committee, which includes physicians and bioethicists from research
facilities throughout the United States, for three years. The major
project currently underway is a conflict of interest policy.
ASCO is a nonprofit organization
with a professional membership of more than 16,000 comprised of clinical
oncologists from all oncology disciplines as well as physicians, nurses
and healthcare professionals with a predominant interest in oncology.
As a leader in cancer patient
care and research, Emory University's Winship Cancer Institute offers
cancer patients new therapies, including more than 200 clinical trials
for all tumor types and stages of cancer. WCI also serves as the coordinating
center for a vast array of resources in medical, surgical, and radiation
oncology, diagnostic imaging and the subspecialties of cancer care throughout
Emory University - from blood and bone marrow stem cell transplants
to internationally recognized breast reconstruction.